A VISIONaerie™ approach
We discover, develop, and commercialize first-in-class therapies for the treatment of patients with glaucoma, retinal diseases and other diseases of the eye
Press ReleaseAerie Pharmaceuticals Reports Second Quarter 2019 Financial Results,... Aerie Pharmaceuticals Completes Enrollment of the Netarsudil... Aerie Pharmaceuticals Announces U.S. Launch of Rocklatan® and...
Aug 16, 4:00 PM ET
52 - WEEK LOW/HIGH